Ankara University / Ankara Üniversitesi

SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis (2022) Efe C, Tascilar K, Gerussi A, Bolis F, Lammert C, Ebik B, Stättermayer AF, et al. Journal article ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma (2022) Dhakal B, Shah N, Kansagra A, Kumar A, Lonial S, Garfall A, Cowan A, et al. Journal article Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial (2022) Terpos E, Dimopoulos MA, Boccadoro M, Delimpasi S, Beksac M, Katodritou E, Moreau P, et al. Journal article Standardized statement for the ethical use of human cadaveric tissues in anatomy research papers: Recommendations from Anatomical Journal Editors-in-Chief (2022) Iwanaga J, Singh V, Takeda S, Ogeng'O J, Kim HJ, Morys J, Ravi KS, et al. Journal article Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis (2021) Efe C, Lammert C, Tascilar K, Dhanasekaran R, Ebik B, Higuera-De La Tijera F, Caliskan AR, et al. Journal article COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network (2021) Ludwig H, Sonneveld P, Facon T, San-Miguel J, Avet-Loiseau H, Mohty M, Mateos MV, et al. Journal article, Review article TROPHY registry — status report (2021) Thomale UW, Auer C, Spennato P, Schaumann A, Behrens P, Gorelyshev S, Bogoslovskaia E, et al. Journal article Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party (2021) Hayden PJ, Eikema DJ, De Wreede LC, Koster L, Kroger N, Einsele H, Minnema M, et al. Journal article Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations (2021) Rosinol L, Beksac M, Zamagni E, Van De Donk NWCJ, Anderson KC, Badros A, Caers J, et al. Journal article, Review article Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial (2021) Dimopoulos MA, Terpos E, Boccadoro M, Delimpasi S, Beksac M, Katodritou E, Moreau P, et al. Journal article